This article was originally published in The Gray Sheet
Executive SummaryPatient enrollment is completed for firm's multi-center European trial of the surgical sealant used to prevent cerebrospinal fluid leaks following neurosurgery, the Lexington, Massachusetts-based firm reports Oct. 26
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.